By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Becton Dickinson today said that it has received both US Food and Drug Administration clearance and a CLIA waiver for its new BD Veritor System for rapid detection of Flu A+B.
By Doug Macron
Alnylam Pharmaceuticals this week unveiled an initiative to apply its RNAi technology to the production of vaccines and announced that GlaxoSmithKline will be its first partner for the platform.
The US Centers for Disease Control said late last week that its newest in vitro diagnostic testing panel for seasonal and pandemic influenza strains has been authorized for use by the US Food and Drug Administration.